Japanese pharmaceutical major Takeda is forging an AI drug-discovery partnership with biotech firm Insilico Medicine with a potential initial value of $600.0 million. Under the partnership announced ...
Under the agreement, Insilico will lead AI-driven discovery to identify molecules meeting predefined scientific and early development criteria, while Takeda will apply its global development ...
MONTFORT, Wis. (WKOW) — The Grant County Sheriff's Office is continuing to investigate the death of a 17-year-old girl who died from a gunshot wound in the fall of 2025. Addison Colomer of Mineral ...
Human advisers remained the top influence on final investment decisions despite growing AI use. AI boosted investor confidence, but human judgment remained decisive. Younger investors embraced AI most ...
A trip to Atlantic City took an unexpected turn for Meek Mill after the Philadelphia rapper revealed he may have suffered a serious hand injury while in town. https ...
Editor’s note: This story was updated June 12, 2026 to include comment from Takeda. It was also updated at 8:40 a.m. on June 13, 2026 to clarify that layoffs could start as soon as July and that the ...
Takeda has won the battle of the TYK2 inhibitors, toppling Bristol Myers Squibb’s Sotyktu to strengthen its hand ahead of an anticipated plaque psoriasis launch next year. The phase 3 trial compared ...
Takeda ( TSE:4502/NYSE:TAK) today announced the U.S. Food and Drug Administration (FDA) has accepted for review its supplemental Biologics License Application (sBLA) for intravenous (IV) ENTYVIO ® ...
If approved, ENTYVIO would be the only gut-focused treatment for patients two years and older with moderately to severely active ulcerative colitis (UC) or Crohn's disease Potential for ENTYVIO to ...
A recent antitrust verdict has prompted Takeda to revise its 2025 financials, putting the drugmaker at a 152 billion Japanese yen ($949.37 million) loss for the fiscal year. Last month, a federal jury ...
Kevin Warsh has made his first two hires after his swearing-in as Federal Reserve chair last month, according to a person familiar with the matter. The two men, Paul Winfree and Daniel Heil, are ...